What is EpiBone?
EpiBone specializes in creating personalized bone and cartilage products using stem cells, offering an innovative solution to skeletal conditions. Their proprietary bioreactor technology harnesses the body's own cells to facilitate natural healing, aiming to eliminate the need for artificial grafts or implants. The company's mission is to transform the treatment of skeletal conditions from temporary fixes to regenerative healing, enabling individuals to lead more active lives by addressing the root causes of pain with natural, lifelong solutions. EpiBone primarily targets younger, active patients seeking long-term recovery.
How much funding has EpiBone raised?
EpiBone has raised a total of $5.3M across 4 funding rounds:
Private Equity
$560K
Debt
$150K
Debt
$341K
Private Equity
$4.3M
Private Equity (2016): $560K with participation from Plum Alley
Debt (2020): $150K led by PPP
Debt (2021): $341K supported by PPP
Private Equity (2025): $4.3M, investors not publicly disclosed
Key Investors in EpiBone
Plum Alley
Plum Alley Ventures is a venture firm that facilitates smart investments in breakthrough technologies aimed at improving the world for humans, industry, and the planet. The company focuses on providing access to well-vetted investment opportunities for a diverse range of investors, enabling them to participate in the technological revolution.
What's next for EpiBone?
With its recent major strategic investment, EpiBone is poised to accelerate the scaling of its regenerative therapies. The company's focus on leveraging stem cell technology for personalized skeletal repair positions it at the forefront of a rapidly evolving biotech landscape. Future developments are expected to center on expanding clinical applications, further refining their bioreactor technology, and potentially forging strategic partnerships to broaden market reach. This substantial backing signals strong investor confidence in EpiBone's potential to disrupt traditional orthopedic treatments and establish a new standard of care for skeletal regeneration.
See full EpiBone company page
